Skip to main content
Premium Trial:

Request an Annual Quote

No Genetic Discrimination Allowed ... Well, Except for Some of You

In the wake of GINA finally becoming law, Brandon Keim at Wired blogs about the "blind spots" the bill didn't deal with. He interviewed Tera Eerkes of Qtrait, who noted that some issues are still unresolved: for one, the law "does not prevent genetic discrimination against people when they are applying for life insurance, or long term care and disability insurance," she notes.

Another concern she has is that overcoming the GINA hurdle will "lead to a surge in demand for personal genetic testing" -- which is not necessarily a bad thing, as long as customers understand that they are often allowing the service companies to sell their genetic information to other organizations.

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.